US President Donald Trump has withdrawn the nomination of Heidi Overton to lead the Food and Drug Administration due to insufficient support in Congress, according to three people familiar with the matter who spoke to Reuters on Tuesday.
The move comes a day before a pivotal Senate committee vote on her nomination. Republicans' one-vote advantage on the panel left the nomination vulnerable to a single GOP defection.
According to two of the people, the White House is weighing Senator Roger Marshall of Kansas, a former obstetrician who recently lost his reelection bid, as a replacement nominee.
Trump nominated Overton, a preventive medicine physician and deputy director of the White House Domestic Policy Council, in August, three months after the resignation of former FDA Commissioner Marty Makary, turning to an "America First" ally to steady a Food and Drug Administration that has lost more than 4,500 staff over the past year.
Overton's nomination was full of challenges from the outset and the withdrawal followed weeks of uncertainty.